Wockhardt forms new manufacturing, research facility in India

By Elaine Rigoli

Tampa, Fla., Sept. 18 - Wockhardt Ltd. has signed a memorandum of understanding with Maharashtra Industrial Development Corp. to establish a special economic zone in Aurangabad, India.

The Wockhardt Group will establish a pharmaceutical and biopharmaceutical manufacturing and research facility at the special economic zone, which will be 107 hectares and will employ an estimated 2,000 people.

Over half of the company's sales now come from Europe and the United States, but India continues to be the group's manufacturing and research base, according to a news release.

The company is a technology-driven pharmaceutical and biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.